Product Information

DONEPEZIL HCL 23 MG TABLET is a generic product labeled by Edenbridge Pharmaceuticals LLC, priced at $0.7354 per EA under NDC 42799095401. Its NADAC has been published 139 times since Feb 7, 2024.

FDA first approved this application on Feb 19, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Donepezil hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

DONEPEZIL HCL 23 MG TABLET

Donepezil hydrochloride
$0.7354per EA
High Outlier

Strength

23 mg/1

NDC

42799095401

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

9/23/2026

Active Ingredients

DONEPEZIL HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA203713

FDA Approved

2/19/2016

TE Code

AB

On Market Since

2/19/2016

Pharmacological Classes

Cholinesterase Inhibitor
Cholinesterase Inhibitors

Price Statistics

The NADAC for DONEPEZIL HCL 23 MG TABLET has been published 139 times since Feb 7, 2024, and over the history we have for it it has risen 14.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7354 per EA
All-time high$0.9378 (Oct 16, 2024)
All-time low$0.5883 (Apr 17, 2024)
52-week high$0.8411
52-week low$0.6722
Median price$0.7481
Average price$0.7461
Largest weekly change+46.2% (Jun 19, 2024)
Weeks tracked139
Tracking sinceFeb 7, 2024

Price History

1W

0.0%

1M

+0.9%

3M

+4.8%

6M

+0.9%

1Y

-12.6%

3Y

N/A

5Y

N/A

All

+14.2%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DONEPEZIL HCL 23 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for DONEPEZIL HCL 23 MG TABLET, manufactured by Edenbridge Pharmaceuticals LLC, is $0.7354 per EA (NDC 42799095401), effective Sep 30, 2026.

How has the price of DONEPEZIL HCL 23 MG TABLET changed over time?

Over the history we have for it, the NADAC for DONEPEZIL HCL 23 MG TABLET has risen 14.2%. It has been tracked across 139 weekly CMS publications since Feb 7, 2024.

What are the highest and lowest recorded NADAC prices for DONEPEZIL HCL 23 MG TABLET?

Since Feb 7, 2024, the NADAC for DONEPEZIL HCL 23 MG TABLET has ranged from a low of $0.5883 (Apr 17, 2024) to a high of $0.9378 (Oct 16, 2024), with a median of $0.7481 per EA.

Are there cheaper alternatives to DONEPEZIL HCL 23 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DONEPEZIL HCL 23 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures DONEPEZIL HCL 23 MG TABLET?

DONEPEZIL HCL 23 MG TABLET (NDC 42799095401) is labeled by Edenbridge Pharmaceuticals LLC, and CMS classifies it as a generic product.